Otonomy pulls plug on ear drug, shares nosedive

(Reuters) - Otonomy Inc said on Wednesday it suspended developing its drug for Meniere's disease, a chronic disorder of the inner ear, after it failed a late-stage trial, sending the drugmaker's shares plummeting in premarket trade.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news